Taibang Biologic, a Biopharmaceutical Product Maker Previously Known as China Biologic ... - Latest Tweet by Bloomberg

Taibang Biologic, a biopharmaceutical product maker previously known as China Biologic Products, picks banks for a Hong Kong IPO at a valuation up to $6 billion, sources say https://t.co/bfz9xaOG2w— Bloomberg (@business) August 12, 2022

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)